Apellis Pharmaceuticals Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
© -
All right. Perfect. Welcome, everyone, to the 30th Annual Healthcare Conference for Crédit Suisse. I'm Tiago Fauth, here. I'm a biotech analyst here at Crédit Suisse. We're joined today by Apellis. We have Tim and we have David from the company, and we're going to have a fireside chat.
So if you guys want to try to ask in a few questions, you can send them my way, I'll try to work those in. The e-mail is Tiago -- T-I-A-G-O F-A-U-T-H @credit-suisse.com, and we can get started.
Questions & Answers
© -
So as usual, we can start bigger picture. Updates. Huge year for you guys. I'm sure you're tired of telling the story. You just had your earnings call, but if you can give us a brief introduction, kind of the key catalysts that you had in 2021 and the outlook going forward. And then we'll take it from there.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
